Shared decision making in type 2 diabetes with a support decision tool that takes into account clinical factors, the intensity of treatment and patient preferences: design of a cluster randomised (OPTIMAL) trial

BACKGROUND: No more than 10-15% of type 2 diabetes mellitus (T2DM) patients achieve all treatment goals regarding glycaemic control, lipids and blood pressure. Shared decision making (SDM) should increase that percentage; however, not all support decision tools are appropriate. Because the ADDITION-...

Descripción completa

Detalles Bibliográficos
Autores principales: den Ouden, Henk, Vos, Rimke C, Reidsma, Carla, Rutten, Guy EHM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369865/
https://www.ncbi.nlm.nih.gov/pubmed/25887759
http://dx.doi.org/10.1186/s12875-015-0230-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369865/
https://www.ncbi.nlm.nih.gov/pubmed/25887759
http://dx.doi.org/10.1186/s12875-015-0230-0

Ejemplares similares